What one share of NovoCure Limited holds
We are a global oncology company with a proprietary platform technology called Tumor Treating Fields ("TTFields"), which are electric fields that exert physical forces to kill cancer cells. Our therapy is delivered through a medical device.
NovoCure Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $6.16 |
|---|---|
| Profit | −$1.31 |
| Capex (buildings and equipment) | $0.20 |
| Free cash flow | −$0.22 |
| Cash and investments | $0.80 |
| Debt | $1.68 |
| Book value | $2.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | $0.90 | −$6.73 | $0.19 | −$4.78 | — | $14.94 |
| 2014 | $1.24 | −$6.46 | $0.07 | −$6.01 | — | $7.29 |
| 2015 | $1.09 | −$3.67 | $0.15 | −$3.44 | — | — |
| 2016 | $0.97 | −$1.54 | $0.07 | −$1.32 | — | $1.63 |
| 2017 | $2.00 | −$0.70 | $0.08 | −$0.46 | — | $1.27 |
| 2018 | $2.70 | −$0.69 | $0.07 | −$0.09 | — | $1.20 |
| 2019 | $3.61 | −$0.07 | $0.11 | $0.17 | — | $2.19 |
| 2020 | $4.54 | $0.18 | $0.14 | $0.77 | — | $4.66 |
| 2021 | $5.17 | −$0.56 | $0.23 | $0.57 | — | $3.95 |
| 2022 | $5.14 | −$0.88 | $0.20 | $0.09 | — | $4.20 |
| 2023 | $4.79 | −$1.95 | $0.25 | −$0.94 | — | $3.39 |
| 2024 | $5.61 | −$1.56 | $0.40 | −$0.64 | — | $3.32 |
| 2025 | $5.88 | −$1.22 | $0.24 | −$0.68 | — | $3.03 |
Common questions about NovoCure Limited
How much does one share of NovoCure Limited earn?
Over the last 12 months, NovoCure Limited lost $1.31 for each share on $6.16 of sales.
Does NovoCure Limited pay a dividend?
NovoCure Limited didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is NovoCure Limited’s book value per share?
NovoCure Limited’s book value is $2.90 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of NovoCure Limited have?
Each share of NovoCure Limited has $0.80 of cash and investments and $1.68 of debt, as of June 30, 2026.
What is NovoCure Limited’s free cash flow per share?
−$0.22 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has NovoCure Limited bought back shares?
NovoCure Limited’s share count rose about 869% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.